Riskpilot← Back to searchSign inGet full accessBEHANDLERVERKET KOLBOTN AS
ASActiveOrg 914063167Kapellveien 17, 1410 KolbotnTraditional, complementary and alternative medicine activities · NACE 8696Est. 20141 employees
Revenue 2024
NOK 6,1M
+19% vs 2023
EBITDA margin
2.8%
+9% vs 2023
Equity ratio
52.0%
Financial strength
Net profit 2024
NOK 134K
+7% vs 2023
| Revenue | NOK 6,1M | +19% |
| EBITDA | NOK 170K | +9% |
| Net profit | NOK 134K | +7% |
| Total assets | NOK 667K | +10% |
| Equity | NOK 347K | +32% |
| Employees | 1 | — |
Legal name
BEHANDLERVERKET KOLBOTN AS
Org number
914063167
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
26. august 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Behandlerverket kolbotn as er en klinikk som er tilknyttet behandlerverket as et nytt, moderne og innovativt konsept innen fysikalsk behandling med klinikker på gateplan. Vårt produkt består av fysioterapi, manuellterapi, kiropraktikk, naprapati, osteopati og rehabilitering.
Address
Kapellveien 17, 1410 Kolbotn
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 379 | 1 679 | 1 871 | 2 116 | 2 215 | 2 637 | 2 243 | 2 463 | 3 374 | 5 134 | 6 132 |
| Staff expenses | −118 | −896 | −1 004 | −1 113 | −1 215 | −1 545 | −1 178 | −1 285 | −1 125 | −896 | −978 |
| EBITDA | 66 | 59 | 63 | 50 | 127 | 24 | −27 | 65 | 145 | 156 | 170 |
| Depreciation & amort. | −102 | −74 | −84 | −76 | −69 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −36 | −15 | −21 | −26 | 58 | 24 | −27 | 65 | 145 | 156 | 170 |
| Net financials | −2 | −3 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
| Profit before tax | −37 | −18 | −21 | −26 | 58 | 24 | −27 | 65 | 145 | 158 | 172 |
| Tax | −0 | −0 | −0 | −0 | 16 | 0 | −10 | 10 | 30 | 33 | 38 |
| Net profit | −37 | −18 | −21 | −26 | 42 | 24 | −17 | 55 | 116 | 125 | 134 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 500 | 738 | 627 | 472 | 510 | 612 | 496 | 448 | 464 | 605 | 667 |
| Equity | −17 | −35 | −56 | −81 | −39 | −15 | −33 | 22 | 138 | 263 | 347 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 517 | 772 | 683 | 553 | 549 | 628 | 529 | 426 | 326 | 342 | 320 |
| Total debt | 517 | 772 | 683 | 553 | 549 | 628 | 529 | 426 | 326 | 342 | 320 |
EBITDA margin
2.8%
This company
15.8%
Market median
-82% vs market
20142024
Equity ratio
52.0%
This company
38.2%
Market median
+36% vs market
20142024
Return on equity
38.6%
This company
18.4%
Market median
+110% vs market
20142024
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
20142024
Asset turnover
9.19×
This company
1.12×
Market median
+721% vs market
20142024
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-08-15 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
GB Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Impuls Helse Norge As | Company | 100.0% | 100.0% | 2023 |
Enoj Holding Invest As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Enoj Holding Invest As
BEHANDLERVERKET KOLBOTN AS Board members of BEHANDLERVERKET KOLBOTN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Espen Holm-Engelstad | Chief Executive Officer | 0 companies |
| Glenn Brose Halvorsen | Chief Executive Officer | 0 companies |
| Bent Roar Ekerhaugen | Chairman | 0 companies |